Neuropathie bei Diabetes und Prädiabetes: Neue Erkenntnisse zur Früherkennung, Pathogenese und Behandlung

• Literatur

• 1 Ziegler D, Keller J, Maier C. et al. Diabetic Neuropathy. Exp Clin Endocrinol Diabetes 2025;
• 2 Ziegler D, Tesfaye S, Spallone V. et al. Screening, diagnosis and management of diabetic sensorimotor polyneuropathy in clinical practice: International expert consensus recommendations. Diabetes Res Clin Pract 2022; 186: 109063
• 3 Herder C, Roden M, Ziegler D. Novel insights into sensorimotor and cardiovascular autonomic neuropathy from recent-onset diabetes and population-based cohorts. Trends Endocrinol Metab 2019; 30: 286-298
• 4 Ziegler D, Bönhof GJ, Strom A. et al. GDS group. Progression and regression of nerve fibre pathology and dysfunction early in diabetes over 5 years. Brain 2021; 144: 3251-3263
• 5 Zaharia OP, Strassburger K, Strom A. et al. German Diabetes Study Group. Risk of diabetes-associated diseases in subgroups of patients with recent-onset diabetes: a 5-year follow-up study. Lancet Diabetes Endocrinol 2019; 7: 684-694
• 6 Maalmi H, Herder C, Bönhof GJ. et al. GDS Group. Differences in the prevalence of erectile dysfunction between novel subgroups of recent-onset diabetes. Diabetologia 2022; 65: 552-562
• 7 Ziegler D, Behler M, Schroers-Teuber M. et al. Near-normoglycaemia and development of neuropathy: a 24-year prospective study from diagnosis of type 1 diabetes. BMJ Open 2015; 5: e006559
• 8 Kück J-L, Bönhof GJ, Strom A. et al. for the GDS group. Impairment in baroreflex sensitivity in recent-onset type 2 diabetes without progression over 5 years. Diabetes 2020; 69: 1011-1019
• 9 Strom A, Strassburger K, Ziegler D. et al. GDS Group. Changes over 10 years in peripheral nerve function in people with well-controlled type 2 diabetes and those with normal glucose tolerance. Neurology 2025; 104: e213780
• 10 Ziegler D, Herder C, Papanas N. Neuropathy in prediabetes. Diabetes Metab Res Rev 2023; e3693
• 11 Bönhof GJ, Herder C, Strom A. et al. Emerging biomarkers, tools, and treatments for diabetic polyneuropathy. Endocr Rev 2019; 40: 153-192
• 12 Bierhaus A, Fleming T, Stoyanov S. et al. Methylglyoxal modification of Na(v)1.8 facilitates nociceptive neuron firing and causes hyperalgesia in diabetic neuropathy. Nat Med 2012; 18: 926-933
• 13 Strom A, Strassburger K, Schmuck M. et al. GDS Group. Interaction between magnesium and methylglyoxal in diabetic polyneuropathy and neuronal models. Mol Metab 2021; 43: 101114
• 14 Singh AK, Bernabucci M, Dvorak NM. et al. Sensory neuron-expressed FGF13 controls nociceptive signaling in diabetic neuropathy models.. J Clin Invest 2025; 135: e183749
• 15 Bönhof GJ, Strom A, Püttgen S. et al. Patterns of cutaneous nerve fibre loss and regeneration in type 2 diabetes with painful and painless polyneuropathy. Diabetologia 2017; 60: 2495-2503
• 16 Bönhof GJ, Strom A, Jung T. et al. Cutaneous carbonyl stress is associated with nerve dysfunction in recent-onset type 2 diabetes. Diabetes Care 2025; 48: 251-258
• 17 Maalmi H, Strom A, Petrera A. et al. GDS Group. Serum neurofilament light chain: a novel biomarker for early diabetic sensorimotor polyneuropathy. Diabetologia 2023; 66 (03) 579-589
• 18 Schlesinger S, Herder C, Kannenberg JM. et al. General and abdominal obesity and incident distal sensorimotor polyneuropathy: Insights into inflammatory biomarkers as potential mediators in the KORA F4/FF4 cohort. Diabetes Care 2019; 42: 240-247
• 19 Herder C, Zhang S, Wolf K. et al. Environmental risk factors of incident distal sensorimotor polyneuropathy: Results from the prospective population-based KORA F4/FF4 study. Sci Total Environ 2023; 858 (03) 159878
• 20 Nguyen PBH, Garger D, Lu D. et al. Interpretable multimodal machine learning (IMML) framework reveals pathological signatures of distal sensorimotor polyneuropathy. Commun Med (Lond) 2024; 4: 265
• 21 Ziegler D, Thorand B, Strom A. et al. Association of transketolase polymorphisms with diabetic polyneuropathy in the general population: The KORA F4 study. Diabetes Metab Res Rev 2024; 40: e3834
• 22 Kwiatkowska KM, Garagnani P, Bonafé M. et al. High-resolution whole-genome DNA methylation revealed unique signatures of painful diabetic neuropathy. Diabetes 2025; db240930
• 23 Bönhof GJ, Strom A, Apostolopoulou M. et al. High-intensity interval training for 12 weeks improves cardiovascular autonomic function but not somatosensory nerve function and structure in overweight men with type 2 diabetes. Diabetologia 2022; 65: 1048-1057
• 24 Ziegler D, Low PA, Litchy WJ. et al. Efficacy and safety of antioxidant treatment with α-lipoic acid over 4 years in diabetic polyneuropathy: The NATHAN 1 Trial. Diabetes Care 2011; 34: 2054-60
• 25 Ziegler D, Hidvégi T, Gurieva I. et al. Efficacy and safety of lacosamide in painful diabetic neuropathy. Diabetes Care 2010; 33: 839-841
• 26 Ziegler D, Duan WR, An G. et al. A randomized double-blind, placebo- and active-controlled study of T-type calcium channel blocker ABT-639 in diabetic patients with peripheral neuropathic pain. Pain 2015; 156: 2013-2020